Core Viewpoint - Liansheng Chemical, established in 2007 and listed in 2022, is a leading fine chemical manufacturer in China, focusing on pharmaceutical and agricultural intermediates, with a full industry chain advantage [1] Group 1: Business Performance - In Q3 2025, Liansheng Chemical reported revenue of 506 million, ranking 56th among 79 companies in the industry, while the industry leader, Sinochem International, achieved revenue of 35.716 billion [2] - The net profit for the same period was 13.7671 million, placing the company 53rd in the industry, with the top performer, Hangyang Co., reporting a net profit of 850 million [2] Group 2: Financial Ratios - As of Q3 2025, Liansheng Chemical's debt-to-asset ratio was 20.98%, an increase from 16.90% year-on-year, which is below the industry average of 34.74% [3] - The gross profit margin for Q3 2025 was 10.84%, slightly up from 10.29% year-on-year, but still below the industry average of 19.93% [3] Group 3: Executive Compensation - The chairman, Mu Jianyu, received a salary of 507,700, a decrease of 900 from the previous year, while the general manager, Yu Kuai, earned 919,200, down 3,600 from 2023 [4] Group 4: Shareholder Information - As of September 30, 2025, the number of A-share shareholders decreased by 16.41% to 7,270, while the average number of circulating A-shares held per account increased by 19.63% to 12,900 [5]
联盛化学的前世今生：2025年三季度营收5.06亿行业排56，净利润1376.71万行业排53